Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.

Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.
复制标题

对大流行期间的Covid-19风险的看法:寻求阿片类药物使用障碍药物的人们的观点。

DOI:
10.1080/07853890.2023.2169342
复制
发表时间:
2023-12
期刊:
影响因子:
4.4
通讯作者:
--
中科院分区:
医学3区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

2019 年冠状病毒病 (COVID-19) 大流行给阿片类药物使用障碍 (OUD) 患者带来了毁灭性后果。然而,对于寻求 OUD 治疗的人们如何看待 COVID-19 的风险以及他们的看法如何与他们的健康行为相互作用,人们知之甚少。 2021 年 9 月至 2022 年 3 月,我们对南加州 32 名寻求 OUD (MOUD) 药物治疗的患者进行了深入访谈。所有采访都是虚拟进行的,持续一到两个小时。访谈被逐字记录和转录。两名定性研究人员独立对笔录进行内容分析,以确定主题。确定了三个主要主题:(1) 对 COVID-19 易感性和严重程度的看法和信念; (2) 与物质使用行为相比,对 COVID-19 风险的看法; (3) 疫苗犹豫。参与者对感染 COVID-19 的易感性以及感染后疾病的严重程度的看法不一。一些参与者报告说采取了预防措施来降低感染 COVID-19 的机会,而其他参与者则报告说,由于药物使用是优先考虑的,因此 COVID 并不是一个大问题。对于许多参与者来说,过量服用药物和其他危险药物使用行为的风险掩盖了对 COVID-19 的担忧。大多数参与者 (n = 23; 72%) 在接受采访时至少接种了一种 COVID-19 疫苗,但超过一半 (n = 19; 59%) 表示对疫苗犹豫不决。由于担心未知的长期副作用以及疫苗与 MOUD 的潜在相互作用,人们对疫苗犹豫不决。参与者对 COVID-19 的严重性表达了不同的看法,一些人采取了预防措施来降低感染 COVID-19 的机会,另一些人则认为感染 COVID-19 的风险低于服药过量的风险。药物使用、社会隔离、疫苗犹豫和 COVID-19 风险行为应作为同时发生的现象进行研究,这些现象具有潜在的重叠关系,可能会影响影响健康和福祉的行为。我们的研究深入了解了 COVID-19 预防措施以及接受 OUD 治疗的人群对疫苗接种的看法和犹豫。
The Coronavirus Disease 2019 (COVID-19) pandemic has had devastating consequences for persons with opioid use disorder (OUD). Yet, little is known about how people seeking treatment for OUD perceive the risks of COVID-19 and how their perception interplays with their health behaviours. In-depth interviews were conducted from September 2021 to March 2022 with 32 patients seeking medication treatment for OUD (MOUD) in Southern California. All interviews were conducted virtually and lasted between one and two hours. Interviews were recorded and transcribed verbatim. Two qualitative researchers independently conducted a content analysis of the transcripts to identify themes. Three primary themes were identified: (1) perceptions and beliefs about COVID-19 susceptibility and severity; (2) perceptions of COVID-19 risk compared to substance use behaviours; and (3) vaccine hesitancy. Participants were mixed in their beliefs of susceptibility to contracting COVID-19 and the severity of the disease if contracted. Some participants reported taking precautions to mitigate their chances of acquiring COVID-19, and other participants reported that COVID was not a big concern as substance use took priority. For many of the participants, COVID-19 concerns were overshadowed by the risk of overdosing on substances and other risky substance use behaviour. Most of the participants (n = 23; 72%) had received at least one COVID-19 vaccine by the time of the interview, but over half (n = 19; 59%) expressed vaccine hesitancy. Vaccine hesitancy was driven by concerns about the unknown long-term side effects and potential interactions of the vaccine with MOUD. Participants expressed diverse perceptions of the seriousness of COVID-19, with some taking precautions to mitigate their chances of acquiring COVID-19 and others perceiving that the risk of contracting COVID-19 was less than the risk of overdosing. Substance use, social isolation, vaccine hesitancy and COVID-19 risk behaviours should be studied as co-occurring phenomena that have potentially overlapping relationships that can influence behaviours that impact health and well-being. Our study provides insight into COVID-19 prevention measures as well as vaccination perceptions and hesitancy among people who received treatment for OUD.
DOI: 10.1177/1049732305276687
发表时间: 2005-11-01
影响因子: 3.2
作者:
Hsieh, HF;Shannon, SE
通讯作者: Shannon, SE
DOI: 10.1001/jama.2021.1169
发表时间: 2021-03-23
期刊: JAMA
影响因子: --
作者:
Baldwin GT;Seth P;Noonan RK
通讯作者: Noonan RK
社会隔离在阿片类药物成瘾中的作用。
DOI: 10.1093/scan/nsab029
发表时间: 2021-07-06
影响因子: 4.2
作者:
Christie NC
通讯作者: Christie NC
DOI: 10.7326/m20-3569
发表时间: 2020-12-15
影响因子: 39.2
作者:
Fisher, Kimberly A.;Bloomstone, Sarah J.;Mazor, Kathleen M.
通讯作者: Mazor, Kathleen M.
DOI: 10.1080/02791072.2020.1836435
发表时间: 2020-10-29
影响因子: 2.8
作者:
Horigian, Viviana E.;Schmidt, Renae D.;Feaster, Daniel J.
通讯作者: Feaster, Daniel J.